Sonoma Pharmaceuticals (SNOA)
(Delayed Data from NSDQ)
$3.02 USD
+0.01 (0.33%)
Updated Aug 6, 2025 03:59 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Sonoma Pharmaceuticals, Inc. has a market cap of $4.94M, which represents its share price of $3.01 multiplied by its outstanding shares number of 1.64M. As a small-cap company, SNOA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SNOA 3.02 +0.01(0.33%)
Will SNOA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SNOA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNOA
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain
SNOA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock
Beat the Market Like Zacks: Starbucks, Shopify, 3M in Focus
Other News for SNOA
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | SNOA ...
Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $3.75M